Multimorbidity — the presence of two or more chronic conditions in a single patient — has become the clinical norm rather than the exception in many patient populations, particularly among older adults, yet most clinical research, guidelines, and medical training remain organized around managing single diseases in isolation. This mismatch between clinical reality and how medical evidence is typically generated and applied represents one of the more significant, persistent challenges in contemporary clinical practice.
Why Single-Disease Guidelines Often Fall Short
Most clinical practice guidelines are developed based on trials that specifically excluded patients with significant comorbid conditions, in order to isolate the effect of a single intervention on a single disease as cleanly as possible. Research examining guideline applicability has found that when multiple single-disease guidelines are applied simultaneously to a patient with several chronic conditions, the combined recommendations can become genuinely difficult to implement — involving excessive medication burden, conflicting dietary or activity recommendations, and appointment schedules that are unrealistic for patients to sustain.
The Problem of Polypharmacy
A direct consequence of applying multiple single-disease guidelines to the same patient is polypharmacy — the use of multiple medications simultaneously, sometimes prescribed by different specialists without full visibility into each other’s prescriptions. Research consistently links polypharmacy with increased risk of drug interactions, adverse effects, and reduced medication adherence, particularly among older adults, who also experience age-related changes in drug metabolism that can further increase these risks even when each individual medication is appropriately prescribed for its target condition.
Research on Treatment Burden
Beyond medication-specific concerns, research increasingly examines the broader concept of “treatment burden” — the cumulative demands that managing multiple conditions places on a patient’s time, cognitive capacity, and daily life, including appointment attendance, self-monitoring tasks, and lifestyle modifications recommended across different conditions. Studies show that excessive treatment burden is independently associated with reduced adherence and worse outcomes, suggesting that treatment plans need to account explicitly for a patient’s overall capacity to manage everything being asked of them, not just the theoretical benefit of each individual recommendation in isolation.
How Multimorbidity Complicates Clinical Decision-Making
Competing Priorities
When conditions have conflicting management priorities — for example, a dietary recommendation beneficial for one condition potentially working against management goals for another — research shows that clinicians and patients need explicit strategies for prioritization, rather than guidelines designed around a single condition being applied without adjustment.
Cumulative Risk Assessment
Research on risk prediction increasingly recognizes that risk calculators and prognostic tools developed for single conditions often don’t accurately capture the combined risk associated with having several conditions simultaneously, an area of ongoing methodological research aiming to develop more accurate multimorbidity-specific risk assessment tools.
Research-Supported Approaches to Multimorbidity Care
Patient Priority-Setting
A growing body of research supports structured approaches to eliciting patient priorities and goals directly, then organizing care around what matters most to the individual patient, rather than defaulting to maximizing adherence to every applicable single-disease guideline regardless of overall burden or patient preference.
Care Coordination and Single Point of Contact
Research on care coordination models — where a single clinician or care team maintains overall responsibility for coordinating care across specialists, rather than each specialist managing their respective condition independently — shows improved outcomes and reduced treatment burden in several studies, compared to fully fragmented specialist-led care.
Deprescribing
An increasingly research-supported practice involves deliberately reviewing a patient’s full medication list to identify and safely discontinue medications where the burden or risk now outweighs likely benefit, particularly relevant for older patients with multimorbidity where preventive medications with long time horizons to benefit may no longer be appropriate given overall life expectancy and treatment burden.
Multimorbidity-Specific Clinical Trials
Recognizing the limitations of single-disease trial evidence, research increasingly calls for, and gradually produces, clinical trials specifically designed to study interventions in patients with defined patterns of multimorbidity, rather than excluding these patients as has been historical practice.
Research on Clinician Training Gaps
Medical education research has identified that most training curricula remain organized around single-disease teaching modules, leaving many clinicians without formal training specifically in multimorbidity management principles despite this being the reality of a large share of their eventual patient population. Research on curriculum reform efforts targeting multimorbidity-specific clinical reasoning shows promise for better preparing clinicians for this common but historically undertaught aspect of practice, though such reforms remain unevenly adopted across medical training programs.
The Growing Prevalence of Multimorbidity in Younger Populations
While multimorbidity has traditionally been associated primarily with older age, research increasingly documents rising rates of multimorbidity among younger and middle-aged adults, driven substantially by rising obesity, diabetes, and mental health condition prevalence occurring earlier in the life course than in previous generations. This shift has research implications beyond geriatric medicine specifically, suggesting that multimorbidity-informed care models need to be integrated more broadly across primary care and general internal medicine practice, rather than treated as a specialty concern relevant mainly to older patient populations.
Research Gaps Worth Addressing
- Expanded multimorbidity-inclusive clinical trial research across more condition combinations
- Development and validation of multimorbidity-specific risk prediction and prognostic tools
- Research on effective care coordination models across varied healthcare system structures
- Research on structured patient priority-setting approaches and their long-term impact on outcomes and satisfaction
Contributing to This Field
Multimorbidity and integrated care research fall within the scope of Medicine as published by journals like IJMS. If you have original research or review papers addressing multimorbidity management, review the IJMS Scope and submit through the Paper Submission page.
Final Thoughts
Multimorbidity exposes a genuine gap between how clinical evidence is traditionally generated and the reality of how most complex patients are actually treated. Closing this gap requires both methodological innovation in how research itself is designed and practical shifts toward more coordinated, patient-priority-driven care models that treat the whole patient rather than a collection of separately managed diagnoses.
For further reading on multimorbidity research, see the National Institute on Aging’s resources on managing multiple chronic conditions.